Literature DB >> 17955514

25 years of Bayesian methods in the pharmaceutical industry: a personal, statistical bummel.

Andrew P Grieve1.   

Abstract

Twenty-five years ago the use of Bayesian methods in Pharmaceutical R&D was non-existent. Today that is no longer true. In this paper I describe my own personal journey along the road of discovery of Bayesian methods to routine use in the pharmaceutical industry. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh：

Year:  2007        PMID： 17955514     DOI： 10.1002/pst.315

Source DB:  PubMed          Journal:  Pharm Stat        ISSN： 1539-1604            Impact factor:   1.894


  3 in total

Review 1.  Bayesian clinical trials in action.

Authors:  J Jack Lee; Caleb T Chu
Journal:  Stat Med       Date:  2012-06-18       Impact factor: 2.373

2.  Adaptive Clinical Trials: Overview of Early-Phase Designs and Challenges.

Authors:  Olga Marchenko; Valerii Fedorov; J Jack Lee; Christy Nolan; José Pinheiro
Journal:  Ther Innov Regul Sci       Date:  2013-11-26       Impact factor: 1.778

Review 3.  Informed decision-making: Statistical methodology for surrogacy evaluation and its role in licensing and reimbursement assessments.

Authors:  Christopher J Weir; Rod S Taylor
Journal:  Pharm Stat       Date:  2022-07       Impact factor: 1.234
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.